Communications for Statistical Applications and Methods

The Korean Statistical Society (한국통계학회)
권호 표지
DOI QR코드

DOI QR Code

Study of age specific lung cancer mortality trends in the US using functional data analysis

  • Tharu, Bhikhari (Department of Mathematics, Spelman College) ;
  • Pokhrel, Keshav (Department of Mathematics and Statistics, University of Michigan-Dearborn) ;
  • Aryal, Gokarna (Department of Mathematics and Statistics, Purdue University Northwest) ;
  • Kafle, Ram C. (Department of Mathematics and Statistics, Sam Houston State University) ;
  • Khanal, Netra (Department of Mathematics, University of Tampa)
  • Received : 2020.06.19
  • Accepted : 2021.01.28
  • Published : 2021.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Lung cancer is one of the leading causes of cancer deaths in the world. Investigation of mortality rates is pivotal to adequately understand the determinants causing this disease, allocate public health resources, and apply different control measures. Our study aims to analyze and forecast age-specific US lung cancer mortality trends. We report functions of mortality rates for different age groups by incorporating functional principal component analysis to understand the underlying mortality trend with respect to time. The mortality rates of lung cancer have been higher in men than in women. These rates have been decreasing for all age groups since 1990 in men. The same pattern is observed for women since 2000 except for the age group 85 and above. No significant changes in mortality rates in lower age groups have been reported for both gender. Lung cancer mortality rates for males are relatively higher than females. Ten-year predictions of mortality rates depict a continuous decline for both gender with no apparent change for lower age groups (below 40).

Keywords

Acknowledgement

The authors would like to thank three anonymous reviewers for their valuable feedback and comments which significantly improved the paper's quality.

References

  1. Alberg AJ, Brock MV, Ford JG, Samet JM, and Spivack SD (2013). Epidemiology of Lung Cancer: Epidemiology of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 123, 21-49. https://doi.org/10.1378/chest.123.1_suppl.21S
  2. Antonia SJ, Brahmer JR, Gettinger S, et al. (2014). Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced NonSmall Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, 90, S2.
  3. Boffetta P, Nyberg F, Agudo A, et al. (1999). Risk of lung cancer from exposure to environmental tobacco smoke from cigars, cigarillos and pipes, International Journal of Cancer, 6, 805-806. https://doi.org/10.1002/(SICI)1097-0215(19991210)83:6<805::AID-IJC18>3.0.CO;2-I
  4. Booth H, Hyndman RJ, Tickle L, and Jong PD (2006). Lee-Carter mortality forecasting, Demographic Research, 15, 289-310. https://doi.org/10.4054/DemRes.2006.15.9
  5. Clements MS, Armstrong BK, and Moolgavkar SH (2005). Lung cancer rate predictions using generalized additive models, Biostatistics, 6, 576-589. https://doi.org/10.1093/biostatistics/kxi028
  6. Corrales L, Scilla K, Caglevic C, Miller K, Oliveira J, and Rolfo C (2018). Immunotherapy in Lung Cancer: A New Age in Cancer Treatment, Advances Experimental Medical Biology, 995, 65-95. https://doi.org/10.1007/978-3-030-02505-2_3
  7. Craven P and Wahba G (1979). Smoothing noisy data with spline functions, Numerische Mathematik, 31, 377-403. https://doi.org/10.1007/BF01404567
  8. Dela Cruz CS, Tanoue LT, and Matthay RA (2011). Lung Cancer: Epidemiology, Etiology, and Prevention, Clinical Chest Medicine, 32, 605-644. https://doi.org/10.1016/j.ccm.2011.09.001
  9. DeSantis CE, Miller KD, Dale W, et al. (2019). Cancer statistics for adults aged 85 years and older, CA: A Cancer Journal for Clinicians, 69, 452-467. https://doi.org/10.3322/caac.21577
  10. Devesa SS, Blot WJ, and Fraumeni Jr. JF (1989). Declining Lung Cancer Rates Among Young Men and Women in the United States: A Cohort Analysis, JNCI: Journal of the National Cancer Institute, 81, 1568-1571. https://doi.org/10.1093/jnci/81.20.1568
  11. Erbas B, Hyndman RJ, and Gertig DM (2007). Forecasting age-specific breast cancer mortality using functional data models, Statistics in Medicine, 26, 458-470. https://doi.org/10.1002/sim.2306
  12. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, Znaor A, and Bray F(2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, International Journal of Cancer, 144, 1941-1953. https://doi.org/10.1002/ijc.31937
  13. Ferraty F and Vieu P (2006). Nonparametric Functional Data Analysis, Springer-Verlag, New York.
  14. Gu C and Kim Y (2008). Penalized likelihood regression: General formulation and efficient approximation, The Canadian Journal of Statistics, 30, 619-628. https://doi.org/10.2307/3316100
  15. Howlader CK, Noone AM, and Krapcho M et al. (2019). SEER Cancer Statistics Review: 1975-2016, National Cancer Institute, Bethesda, from : https://seer.cancer.gov/csr/1975-2016/, based on November 2018 SEER data submission, posted to the SEER web site, April.
  16. Hyndman RJ (2019). https://cran.r-project.org/web/packages/ftsa/citation.html
  17. Hyndman RJ and Booth H (2008). Stochastic population forecasts using functional data models for mortality, fertility and migration, International Journal of Forecasting, 24, 32-342.
  18. Hyndman RJ, Koehler AB, Ord JK, Snyder RD (2008). Forecasting with Exponential Smoothing: a State Space Approach, Berlin: Springer.
  19. Hyndman RJ and Shang HL (2010). Rainbow Plots, Bagplots, and Boxplots for Functional Data, Journal of Computational and Graphical Statistics, 19, 29-45. https://doi.org/10.1198/jcgs.2009.08158
  20. Hyndman RJ and Ullah MS (2007). Robust forecasting of mortality and fertility rates: A functional data approach, Computational Statistics Data Analysis, 51, 4942-4956. https://doi.org/10.1016/j.csda.2006.07.028
  21. Jeon J, Holford TR, Levy DT, et al. (2018). Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach, Annals of Internal Medicine, 169, 684-693. https://doi.org/10.7326/M18-1250
  22. John U and Hanke M (2016). Age and Sex-Specific Trends in Lung Cancer Mortality over 62 Years in a Nation with a Low Effort in Cancer Prevention, International Journal of Environmental Research and Public Health, 13, 362.
  23. Kafle RC, Khanal N, and Tsokos CP (2014). Bayesian age-stratified joinpoint regression model: an application to lung and brain cancer mortality, Journal of Applied Statistics, 41, 2727-2742. https://doi.org/10.1080/02664763.2014.927840
  24. Kazerouni N, Alverson CJ, Redd SC, Redd SC, Mott JA, and Mannino DM (2004). Sex Differences in COPD and Lung Cancer Mortality Trends-United States, 1968-1999, Journal of Women's Health, 13, 17-23. https://doi.org/10.1089/154099904322836410
  25. McCarthy WJ, Meza R, Jeon J, and Moolgavkar SH (2012). Lung Cancer in Never Smokers: Epidemiology and Risk Prediction Models, Risk Analysis, Chapter 6 , 32, 69-84.
  26. Negri E, La Vecchia C, Levi F, Randriamiharisoa A, Decarli A, and Boyle P (1990). The application of age, period and cohort models to predict Swiss cancer mortality, Journal of Cancer Research and Clinical Oncology, 116, 207-214. https://doi.org/10.1007/BF01612679
  27. Patel JD, Bach PB, and Kris MG (2004). Lung Cancer in US Women: A Contemporary Epidemic, Journal of the American Medical Association, 291, 1763-1768. https://doi.org/10.1001/jama.291.14.1763
  28. Pauk N, Kubik A, et al. (2005). Lung cancer in women, Lung Cancer, 48, 1-9. https://doi.org/10.1016/j.lungcan.2004.10.009
  29. Ramsay JO and Dalzell CJ (1991). Some Tools for Functional Data Analysis, Journal of the Royal Statistical Society: Series B (Methodological), 53, 539-561. https://doi.org/10.1111/j.2517-6161.1991.tb01844.x
  30. Ramsay JO and Silverman BW (2005). Functional Data Analysis, Springer, New York.
  31. Rapp E, Pater JL, Willan A, et al. (1988). Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer report of a Canadian multicenter randomized trial, Journal of Clinical Oncology, 6, 633-641. https://doi.org/10.1200/JCO.1988.6.4.633
  32. Rosenberg PS and Anderson WF (2011). Age-Period-Cohort Models in Cancer Surveillance Research: Ready for Prime Time?, Cancer Epidemiology Biomarkers Prevention, 20, 1263-1268. https://doi.org/10.1158/1055-9965.EPI-11-0421
  33. Roser M and Ritchie H (2020). Cancer, Our world in data.
  34. SEER (2019). Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1975-2016), National Cancer Institute, DCCPS, Surveillance Research Program based on the November 2018 submission.
  35. Siegel RL, Miller KD, and Jemal A (2019). Cancer statistics, CA: A Cancer Journal for Clinicians, 69, 7-34. https://doi.org/10.3322/caac.21551
  36. Siegel RL, Miller KD, and Jemal A (2020). Cancer statistics, CA: A Cancer Journal for Clinicians, 70, 7-30. https://doi.org/10.3322/caac.21590
  37. Smith TR and Wakefield J (2016). A Review and Comparison of Age-Period-Cohort Models for Cancer Incidence, Statistical Science, 31, 591-610.
  38. Tabatabai MA, Kengwoung-Keumo JJ, Oates GR, Guemmegne JT, Akinlawon A, Ekadi G, Fouad MN, and Singh KP (2016). Racial and Gender Disparities in Incidence of Lung and Bronchus Cancer in the United States: A Longitudinal Analysis, PloS One, 11.
  39. Takahashi H, Okada M, and Kano K (2001). Age-Period-Cohort Analysis of Lung Cancer Mortality in Japan, 1960-1995, Journal of Epidemiology, 11, 151-159. https://doi.org/10.2188/jea.11.151
  40. Tharu BP, Kafle RC, and Tsokos CP (2015). Bayesian age-period-cohort model of lung cancer mortality, Epidemiology Biostatistics and Public Health, 12.
  41. Thun MJ (2008). Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies, PLOS Medicine, 5. https://doi.org/10.1371/image.pmed.v05.i01
  42. Wood SN (1994). Monotonic Smoothing Splines Fitted by Cross Validation, SIAM Journal on Scientific Computing, 15, 1126-1133. https://doi.org/10.1137/0915069